Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Kile Green.

Newcastle AuthorsTitleYearFull text
Issac Goh Kai'En
Dr Rachel Botting
Antony Rose
Dr Simone Webb
Justin Engelbert
et al.
Yolk sac cell atlas reveals multiorgan functions during human early development2023
Dr Kile Green
Tim Hicks
Amanda Winter
Dr Lisa Shaw
Professor Christopher Price
et al.
Perceived feasibility, facilitators and barriers to incorporating point-of-care testing for SARS-CoV-2 into emergency medical services by ambulance service staff: a survey-based approach2022
Tim Hicks
Amanda Winter
Dr Kile Green
Dr David Price
Dr Joy Allen
et al.
Care pathway and prioritization of rapid testing for COVID-19 in UK hospitals: a qualitative evaluation2021
Dr Gary Reynolds
Dr Peter Vegh
Dr James Fletcher
Dr Beth Poyner
Dr Emily Stephenson
et al.
Developmental cell programs are co-opted in inflammatory skin disease2021
Dr Arianna Bianchi
Letizia Marchetti
Dr Hannah Paish
Dr Kile Green
Dr Dina Tiniakos
et al.
Moderate Exercise Inhibits Age-Related Inflammation, Liver Steatosis, Senescence, and Tumorigenesis2021
Dr Jana Suklan
Dr Sarah Hill
Dr Sam Urwin
Dr Kile Green
Amanda Winter
et al.
Utility of Routine Laboratory Biomarkers to Detect COVID-19: A Systematic Review and Meta-Analysis2021
Dr Joy Allen
Dr Sara Graziadio
Dr Kile Green
Dr Jana Suklan
Amanda Winter
et al.
At what times during infection is SARS-CoV-2 detectable and no longer detectable using RT-PCR-based tests? A systematic review of individual participant data2020
Dr Urszula Cytlak-Chaudhuri
Dr Anastasia Resteu
Sarah Pagan
Dr Kile Green
Dr Paul Milne
et al.
Differential IRF8 Transcription Factor Requirement Defines Two Pathways of Dendritic Cell Development in Humans2020
Dr Laura Jardine
Dr Urszula Cytlak-Chaudhuri
Dr Merry Gunawan
Dr Gary Reynolds
Dr Kile Green
et al.
Donor monocyte-derived macrophages promote human acute graft-versus-host disease2020
Dr Sara Graziadio
Amanda Winter
Dr Clare Lendrem
Dr Jana Suklan
Dr Will Jones
et al.
How to Ease the Pain of Taking a Diagnostic Point of Care Test to the Market: A Framework for Evidence Development.2020
Dr Dorin-Mirel Popescu
Dr Rachel Botting
Dr Emily Stephenson
Dr Kile Green
Dr Simone Webb
et al.
Decoding human fetal liver haematopoiesis2019
Dr Laura Jardine
Dr Sarah Wiscombe
Dr Gary Reynolds
Dr David McDonald
Andrew Fuller
et al.
Lipopolysaccharide inhalation recruits monocytes and dendritic cell subsets to the alveolar airspace.2019
Dr Rachel Botting
Dr Dorin-Mirel Popescu
Dr Roser Vento-Tormo
Emily Stephenson
Dr Kile Green
et al.
Spatiotemporal immune zonation of the human kidney2019
Dr Venetia Bigley
Dr Urszula Cytlak-Chaudhuri
Dr Laura Jardine
Dr Kile Green
Dr Merry Gunawan
et al.
Biallelic interferon regulatory factor 8 mutation: A complex immunodeficiency syndrome with dendritic cell deficiency, monocytopenia, and immune dysregulation2018
Dr Kile Green
Katie Best
Professor Muzlifah Haniffa
Epithelial damage and tissue γδ T cells promote a unique tumor-protective IgE response2018
Dr Emily Mavin
Dr Lindsay Nicholson
Dr Kile Green
Professor Anne Dickinson
Dr Xiao Wang
et al.
Mesenchymal stromal cell-derived extracellular vesicles attenuate dendritic cell maturation and function2018
Dr Rachel Crossland
Jean Norden
Dr Kile Green
Dr Kim Pearce
Dr Clare Lendrem
et al.
Expression of Serum microRNAs is Altered During Acute Graft-versus-Host Disease2017
Dr Kile Green
Dr Kim Pearce
Dr Laura Jardine
Dr Venetia Bigley
Professor Graham Jackson
et al.
Impact of Alemtuzumab Scheduling on Graft-versus-Host Disease after Unrelated Donor Fludarabine and Melphalan Allografts2017
Dr Rachel Crossland
Dr Kile Green
Dr Christopher Bacon
Dr Vikki Rand
Direct digital profiling of multiplexed mRNA expression from degraded formalin fixed paraffin embedded aggressive paediatric B-cell lymphoma tumour tissue2015
Dr Naomi McGovern
Dr Merry Gunawan
Dr Laura Jardine
Dr Elizabeth Poyner
Dr Kile Green
et al.
Human tissue mononuclear phagocyte system revisited2014
Dr Laura Jardine
Dr Kile Green
Professor Graham Jackson
Professor Matthew Collin
Synergy of Unrelated Donor and Full Intensity Conditioning Breaks the Control of Graft Versus Host Disease By Alemtuzumab2014
Dr Kile Green
Dr Laura Jardine
Dr Kim Pearce
Dr Venetia Bigley
Professor Graham Jackson
et al.
Defining The Optimal Dose Of Alemtuzumab In Unrelated Donor Reduced Intensity Allografts: A UK Retrospective Study2013